The number of patients who have suffered bladder cancer as a result of their use of Actos to treat diabetes has climbed to significant numbers. In fact, there have been so many Actos bladder cancer victims filing lawsuits over health problems they have suffered that the federal court system has coordinated many of them in what is called a multi-district litigation in Louisiana.
The Louisiana multi-district litigation involves common lawsuits that have been filed against Asian pharmaceutical giant Takeda Pharmaceuticals, which developed the medication.
The lawsuits involve claims by diabetes patients who took Actos that Takeda knew of the links between the medication and increased risks of developing bladder cancer but did not take adequate action to warn patients, health care professionals and government regulators.
What is contained in an Actos lawsuit? One plaintiff’s claims are similar to the others in alleging he “was injured as a result of his use of Actos, and therefore seeks damages for pain and suffering, ascertainable economic losses, attorneys’ fees, reimbursement of cost of obtaining Actos, reimbursement for all past, present and future health and medical care costs related to Actos.”
The victim also is seeking compensation for his wife who, according to the lawsuit “was deprived of the care, consideration, compassion, consortium and concern” from the victim.